Source: Breathe, 13 (4) 291; 10.1183/20734735.001917
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Joanna Domagala-Kulawik, Agata Raniszewska. How to evaluate the immune status of lung cancer patients before immunotherapy. Breathe, 13 (4) 291; 10.1183/20734735.001917

Member's Comments

No comment yet.

Related content which might interest you: How to define the immune status of lung cancer patient Source: International Congress 2015 – Stop immune tolerance in lung cancer! Year: 2015 Impact of antibiotics on immunotherapy response in lung cancer patients Source: International Congress 2019 – Treatment of lung cancer Year: 2019 Re-challenge of immunotherapy in a lung cancer patient Source: Virtual Congress 2021 – Lung cancer grand round Year: 2021 From ineffective tumor immune response to immunomodulation in lung cancer Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies? Year: 2017 How to manage immune-related adverse effects in lung cancer patients under immunotherapy Source: CME Online 2019 Year: 2018 Boosting immunotherapy in lung cancer  Source: International Congress 2017 – ME9 Boosting immunotherapy in lung cancer Year: 2017 The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 674s Year: 2006 Possible predictors of the bronchodilation test response within lung function assessment of patients with operable lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 326s Year: 2005 Impact of COPD on prognosis of lung cancer: the prespective of immunotherapy treatment Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Radiation therapy for augmenting the efficacy of immunotherapy in advanced non-small cell lung cancer: a case-controlled study Source: ERJ Open Res, 6 (1) 00189-2019; 10.1183/23120541.00189-2019 Year: 2020 Chemotherapy improves low performance status lung cancer patients Source: Eur Respir J 2007; 30: 1186-1192 Year: 2007 The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 78s Year: 2005 Eosinophilia in lung cancer patients treated with immunotherapy Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 The effect of nutritional indicators on prognosis of patients with advanced lung cancer Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 A case of pulmonary tuberculosis development after receiving immune check point inhibitor in an advanced non-small cell lung cancer Source: International Congress 2019 – Lung cancer? Year: 2019 Identification of predictive biomarkers of immunotherapy response in non-small cell lung cancer by multiparametric analysis Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 CAR T-cell therapy for lung cancer Source: International Congress 2017 – A novel approach to lung cancer Year: 2017 Alterations of serum inflammatory biomarkers in the healthy and lung cancer patients before and post chemotherapy Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Ras peptide-specific vaccination in patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2006 - Lung cancer treatment Year: 2006